Cover Image

Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases

ABSTRACT Objectives: to identify and characterize the potential serious drug interactions in patients hospitalized with cardiovascular diseases, relating them to the schedules established for drug administration by nurses. Methods: a documentary, quantitative and sectional research. Ninety-nine pres...

Full description

Saved in:

Bibliographic Details
Main Authors:	Natália da Palma Sobrinho (Author), Juliana Faria Campos (Author), Rafael Celestino da Silva (Author)
Format:	Book
Published:	Associação Brasileira de Enfermagem.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse drug reactions related to potential serious drug interactions in patients with cardiovascular diseases
by: Natália da Palma Sobrinho, et al.
Published: (2020)

Drug interactions resulting from scheduling and errors in the preparation of antibacterials
by: Francisco Gilberto Fernandes Pereira, et al.
Published: (2018)

Categorical Analysis of Database Consistency in Reporting Drug-Drug Interactions for Cardiovascular Diseases
by: Liana Suciu, et al.
Published: (2024)

Potential drug-drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
by: Zarka Akbar, et al.
Published: (2021)

Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
by: Yong-Jian Geng, et al.
Published: (2021)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022)

Possibility of Drug-Drug Interaction through Prescription Analysis at the National Institute of Cardiovascular Disease (NICVD), Bangladesh
by: Mohammad Borhan Uddin, et al.
Published: (2016)

Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration
by: Matthew L. Banks, et al.
Published: (2012)

Survey of community pharmacists' opinions on drug scheduling in Ontario and Québec
by: Nardine Nakhla, et al.
Published: (2024)

Evaluation of the rational prescription of linezolid, the prevalence of thrombocytopenia and major drug interactions in patients with cardiovascular diseases: are there any cautions?
by: Mehrnoush Dianatkhah, et al.
Published: (2024)

Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
by: Aleksić Dejan Z., et al.
Published: (2021)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
by: Assefa YA, et al.
Published: (2020)

Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions
by: Min-Koo Choi, et al.
Published: (2021)

Handoff communication in intensive care: links with patient safety
by: Grazielle Rezende da Silva dos Santos, et al.
Published: (2018)

Oncology nurses awareness of drug interactions
by: Azize Karahan, et al.
Published: (2015)

Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis
by: Jane Louisa Debus, et al.
Published: (2022)

Potential of drug interactions as a cause of adverse drug reactions in patients with kidney diseases
by: Tahereh Gholipur Shahraki, et al.
Published: (2020)

Drug-Drug Interactions
Published: (2021)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
by: Juveriya Farooq, et al.
Published: (2023)

MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015)

MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015)

Patients with dementia: prevalence and type of drug-drug interactions
by: María Cristina Muñoz-Contreras, et al.
Published: (2024)

Equipment failure: conducts of nurses and implications for patient safety
by: Gabriella da Silva Rangel Ribeiro, et al.

Effect of alternative income assistance schedules on drug use and drug-related harm: a randomised controlled trial
by: Lindsey Richardson, DPhil, et al.
Published: (2021)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
by: Michael Hecker, et al.
Published: (2022)

Developing practical recommendations for drug-disease interactions in patients with hypertension
by: Kübra Özokcu, et al.
Published: (2024)

Drug interactions and adverse events in elderly heart disease patients
by: Fernanda Carolina Cruz Evangelista, et al.
Published: (2021)

Drug-drug interactions of tacrolimus
by: Rančić Nemanja K., et al.
Published: (2015)

Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer's Disease
by: Georgios N. Dimitrakopoulos, et al.
Published: (2023)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
by: Bianca Papotti, et al.
Published: (2021)

Potential drug-drug interactions in hospitalized patients with COVID-19.
by: Danuta Szkutnik-Fiedler, et al.
Published: (2023)

Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome
by: Thorsten Bischof, et al.
Published: (2024)

The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders
by: O. O. Kirilochev, et al.
Published: (2020)

Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021)

Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug-Drug and Drug-Disease Interactions of Apatinib
by: Hongrui Liu, et al.
Published: (2021)

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)
by: Tatiana A. Marins, et al.
Published: (2021)

Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions
by: Hanna Justad, et al.
Published: (2021)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions
by: Martina Hahn, et al.
Published: (2021)

Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units
by: Flávia Medeiros Fernandes, et al.
Published: (2019)

Implications of antibacterial scheduling in newborns in clinical nursing practice
by: Waltemberg Moreira da Silva, et al.
Published: (2015)